CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Control Contact Lens (stenfilcon A) +1 moredevice
Likely dose
stenfilcon A (control) and senofilcon A (test) contact lenses worn one week eachAI-extracted
Key inclusion· 6
  • Age 18-35 years
  • Full eye examination within past 2 years
  • Ability to wear study lenses at least 8 hours daily, 7 days/week
  • Habitual soft contact lens wearer for ≥3 months
Key exclusion· 7
  • Concurrent participation in any clinical or research study
  • Active ocular disease and/or infection contraindicating contact lens wear
  • Systemic condition that may affect study outcomes
  • Systemic or topical medications that may affect contact lens wear or study outcomes

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05805059
NCT05805059N/ACompleted

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

CooperVision, Inc.·interventional·Posted Apr 7, 2023·Updated Sep 26, 2024

In Brief

A clinical study evaluating Control Contact Lens (stenfilcon A) and Test Contact Lens (senofilcon A) for Myopia. Completed, enrolled 68 participants across 4 sites in 2 countries.

Detailed Summary

The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesCanada, United States

Timeline

N/ACompletedFinished
202420252026
First PostedApr 7, 2023
Enrollment StartApr 14, 2023
Primary CompletionJun 20, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.2 years ago

Interventions

Control Contact Lens (stenfilcon A)device

one week wear

Test Contact Lens (senofilcon A)device

one week of wear